Desktop Site
|
28 Mar 24 | 15:59
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
Notices
|
S&P
BSE SENSEX
73,651.35
+655.04
+0.90 %
Corporate Announcement
Security Code
532296
Company
Glenmark Pharmaceuticals Ltd
Exchange Received Time
05/11/2019 16:43:50
Exchange Disseminated Time
05/11/2019 16:43:55
Time Taken
00:00:05
Board Meeting Intimation for Considering And Approving Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended September 30, 2019 |
11/05/19 16:43
GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the Second Quarter and Half Year ended September 30, 2019.
Further, as per the "Code of Conduct for Prevention of Insider Trading" and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the Company has intimated its Directors and other designated persons regarding the closure of trading window from September 30, 2019 to November 16, 2019 (both days inclusive) for the purpose of approval of Unaudited Financial Results for the Second Quarter and Half Year ended September 30, 2019.
Attachment
<< Back
Recently Viewed